Ricerca
Didattica
Soluzioni
Accedi
IT
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
State Key Laboratory of Bioactive Substance and Function of Natural Medicines,
Institute of Materia Medica,
State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica
Xingkai Wang has not added Biography.
If you are Xingkai Wang and would like to personalize this page please email our Author Liaison for assistance.
A benzoxazole compound as a novel MEK inhibitor for the treatment of RAS/RAF mutant cancer.
International journal of cancer Jul, 2019 | Pubmed ID: 30628057
Chinese Academy of Medical Sciences and Peking Union Medical College
Lulu Zhang*,1,
Siqi Zhang*,2,
Wenyu Wu1,
Xingkai Wang2,
Jieting Shen2,
Dongyuan Wang4,
Kuan Hu*,2,3,
Ming-Rong Zhang*,3,
Feng Wang*,1,
Rui Wang*,2
1Department of Nuclear Medicine, Nanjing First Hospital, Nanjing Medical University,
2State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College,
3Department of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology,
4Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Riservatezza
Condizioni di utilizzo
Politiche
Contattaci
SUGGERISCI JOVE ALLA BIBLIOTECA
Newsletter di JoVE
JoVE Journal
Raccolta di metodi
JoVE Encyclopedia of Experiments
Archivio
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Sportello unico per docenti
Autori
Personale delle biblioteche
Accesso
CHI SIAMO
Copyright © 2024 MyJoVE Corporation. Tutti i diritti riservati